Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Securities Class Action

Securities fraud litigation history and active cases

In Litigation

2

Settlement

0

Closed

0

Total Settlement

$0

Aquestive Therapeutics, Inc. (AQST) Class Action Lawsuit (March 2026)

In Litigation

3:26cv2317 • March 5, 2026

Class Period Start

June 16, 2025

Class Period End

January 8, 2026

PSLRA Deadline

May 4, 2026

Case Allegations

10b5

Statutes of Repose

Jun 16, 2028

Country

United States

Court

Federal Court

Docket History

Mar 5, 2026

First Filed Complaint

A securities fraud class action complaint has been filed on behalf of certain investors in Aquestive Therapeutics, Inc..

Aquestive Therapeutics, Inc. (AQST) Class Action Lawsuit (March 2021)

In Litigation

3:21cv3751 • March 1, 2021

Class Period Start

August 7, 2019

Class Period End

September 25, 2020

PSLRA Deadline

April 30, 2021

Case Allegations

10b5

Statutes of Repose

Aug 7, 2022

Country

United States

Court

Federal Court

Docket History

Apr 7, 2023

Voluntary Dismissal

The plaintiff in this action has chosen not to proceed with the case. Once a case is voluntary dismissed, the courts will usually close the case and no further action will be taken.

Mar 14, 2023

Motion to Dismiss Denied in Part

The court has determined that plaintiffs have adequately alleged some of their claims, but have failed to adequately allege other claims. The judge has therefore denied in part the motion to dismiss filed by defendants and written an order stating which claims are dismissed and which remain. The case will proceed and parties will litigate the remaining claims.

Aug 16, 2021

Motion to Dismiss

After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.

Jun 25, 2021

First Amended Complaint

A new complaint has been filed on behalf of certain investors in Aquestive Therapeutics, Inc.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.

May 7, 2021

Scheduling Order

View all Updates

TOP